Automated CPR device trials cast uncertainty over product's value
This article was originally published in Clinica
Executive Summary
Conflicting results from three US trials of an automated cardiopulmonary resuscitation (CPR) device have thrown confusion on the issue whether the technology is better at helping to resuscitate cardiac arrest patients than traditional manual chest compression, writes Neena Brizmohun at the American Heart Association (AHA) meeting in Dallas, Texas.